Alexander Stein on Muck Rack

Alexander Stein

New York
As seen in: Medium, Forbes, Nature, Wiley Online Library, PLOS ONE, Therapeutic Advances in Medical Oncology, Yahoo Finance, JAMA Oncology, CHIP, Genbeta and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexander

Contact Alexander, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group

|
By Isabella C. Wiest, Lena Dreikhausen, Laurence Albigès, Katharina Leucht, Stefan Rieken, Emilio Esteban, Friedemann Zengerling, Joseph Tintelnot, Marc-Oliver Grimm, Farastuk Bozorgmehr, Petros Christopoulos, Alexander Stein, Mascha Binder, Nicolai Härtel, Konrad Klinghammer, Viktor Grünwald, Michael Pogorzelski, Matthias Ebert, Ralph Keller, Marcos Marin-Galiano, Johannes Meran
| Nature Verified
Abstract We explored the association of immune-related adverse events (irAE), along with prior and concomitant antibiotic and steroid use, on oncological outcomes following immune checkpoint inhibitor (ICI) treatment in various solid tumours.
Open in Who Shared Issue with article?

From Stewart to Squires: The PTAB’s First-Year Reset in IPRs and PGRs

|
By Jacob Peterson, Alexander Stein, Dion Bregman
| morganlewis.com
Adversarial proceedings at the US Patent Trial and Appeal Board (PTAB) have undergone significant changes in just one year. The biggest change is not a single doctrinal development but a redefinition of institution itself. Institution decisions are no longer handled by panels of administrative patent judges.
Open in Who Shared Issue with article?

USPTO Introduces Pre-Order Patent Owner Submission in Ex Parte Reexaminations

|
By Dion Bregman, Alexander Stein, Christian Boettcher
| morganlewis.com
Ex parte reexamination proceedings now have a new twist: patent owners will have the option to file a pre-order paper before the Office determines whether a substantial new question of patentability (SNQ) has been raised. While a patent-owner statement was previously available after the SNQ determination, this new pre-order paper provides an earlier opportunity to persuade the Office that a request should be denied.
Open in Who Shared Issue with article?
See all 131 licensed articles (133 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified